Annexon, Inc. (ANNX)
4.01
+0.60
(+17.60%)
USD |
NASDAQ |
Oct 19, 16:00
4.09
+0.08
(+2.00%)
After-Hours: 20:00
Annexon Price to Book Value : 3.763 for Oct. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 19, 2026 | 3.763 |
| October 16, 2026 | 3.20 |
| October 15, 2026 | 3.378 |
| October 14, 2026 | 3.444 |
| October 13, 2026 | 3.594 |
| October 12, 2026 | 3.716 |
| October 09, 2026 | 3.772 |
| October 08, 2026 | 3.754 |
| October 07, 2026 | 3.763 |
| October 06, 2026 | 3.782 |
| October 05, 2026 | 3.941 |
| October 02, 2026 | 3.932 |
| October 01, 2026 | 3.866 |
| September 30, 2026 | 3.970 |
| September 29, 2026 | 3.876 |
| September 28, 2026 | 3.763 |
| September 25, 2026 | 3.416 |
| September 24, 2026 | 3.566 |
| September 23, 2026 | 3.632 |
| September 22, 2026 | 3.923 |
| September 21, 2026 | 3.960 |
| September 18, 2026 | 3.970 |
| September 17, 2026 | 3.913 |
| September 16, 2026 | 3.688 |
| September 15, 2026 | 3.679 |
| Date | Value |
|---|---|
| September 14, 2026 | 3.707 |
| September 11, 2026 | 3.697 |
| September 10, 2026 | 3.885 |
| September 09, 2026 | 4.101 |
| September 08, 2026 | 4.382 |
| September 04, 2026 | 4.570 |
| September 03, 2026 | 4.542 |
| September 02, 2026 | 4.626 |
| September 01, 2026 | 4.589 |
| August 31, 2026 | 4.636 |
| August 28, 2026 | 4.664 |
| August 27, 2026 | 4.927 |
| August 26, 2026 | 4.683 |
| August 25, 2026 | 4.833 |
| August 24, 2026 | 4.748 |
| August 21, 2026 | 4.758 |
| August 20, 2026 | 4.861 |
| August 19, 2026 | 5.161 |
| August 18, 2026 | 4.955 |
| August 17, 2026 | 4.814 |
| August 14, 2026 | 4.964 |
| August 13, 2026 | 4.936 |
| August 12, 2026 | 5.002 |
| August 11, 2026 | 5.011 |
| August 10, 2026 | 5.058 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.608 |
| Alnylam Pharmaceuticals, Inc. | 23.04 |
| Anika Therapeutics, Inc. | 1.971 |
| Savara, Inc. | 6.620 |
| Vericel Corp. | 5.583 |
Price to Book Value Related Metrics
| Price | 4.01 |
| Earnings Yield | -28.61% |
| Market Cap | 700.16M |